Anti-BAP1 [3C11] Antibody

This mouse IgG1k monoclonal antibody was generated against full-length human BRCA-1 associated protein (BAP1) and recognizes human BAP1.

Highlights:

  • Specific for human BAP1
  • Recommended for Western Blot, Immunoprecipitation, and Immunofluorescence applications

BAP1 interacts with BRCA1 and interferes with BRCA1 E3 ubiquitin ligase function. BAP1 is a deubiquitinating enzyme that mediates deubiquitination of histone H2A and HCFC1. BAP1 is a tumor suppressor, it binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression and regulates of cell growth by mediating deubiquitination of HCFC1 N-terminal and C-terminal chains. BAP1 disrupts BRCA1 and BARD1 heterodimer activity by inhibiting their ability to mediate ubiquitination and autoubiquitination.

From the laboratory of Frank J. Rauscher, III, PhD, The Wistar Institute.

The Investigator's Annexe Part of The Investigator's Annexe program.

Catalog Number Product DataSheet Size AVAILABILITY Price Qty
EWI012
Anti-BAP1 [3C11] Antibody
100ug In stock
Regular Price:$310.00
On Sale:
Specifications

Product Type: Antibody
Antigen: BAP1 (BRCA-1 associated protein)
Accession ID: Q92560
Molecular Weight: 90 kDa
Isotype: IgGk1
Clonality: Monoclonal
Clone Name: 3C11
Reactivity: Human
Immunogen: Full length Human BAP1
Species Immunized: Mouse
Epitope: Amino acids 337-440
Purification Method: Affinity purified
Buffer: BSA/sodium azide
Tested Applications: WB (1:1000); IP (10mg per reaction) IF
Concentration: 1mg/mL
Storage: -20C, avoid freeze thaw cycles
Shipped: Cold packs

Provider
From the laboratory of Frank J. Rauscher, III, PhD, The Wistar Institute.
References
  1. Abdel-Wahab O, Adli M, LaFave LM, Gao J, Hricik T, Shih AH, Pandey S, Patel JP, Chung YR, Koche R, Perna F, Zhao X, Taylor JE, Park CY, Carroll M, Melnick A, Nimer SD, Jaffe JD, Aifantis I, Bernstein BE, Levine RL. ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. Cancer Cell. 2012 Aug 14;22(2):180-93. doi: 10.1016/j.ccr.2012.06.032

If you publish research with this product, please let us know so we can cite your paper.

Loading...